Injectable Bags Market Overview :
Injectable bags are used to provide life sustaining IV fluids, medications, and electrolytes to the patients. Through these bags, the intravenous therapy liquid directly enters into the vein and shows faster therapeutic action compared to oral therapy. The market for injectable bags are on high demand owing to its rising adoption in injection based therapeutic practices. For dispensing drugs or vital nutrients to patients who are not in the state to consume medicines or essential nutrients orally, these bags turn out to be the perfect solution.
Rising adoption of injection-based therapies, rise in awareness about the benefits of transportation of fluids intravenously for patients, and increasing prevalence of chronic diseases are the major factors driving the growth of the global injectable bags market. However, risk of infection and injuries to vein due to long-term administration of needle, and stringent regulatory policies may limit the market from growing. Moreover, rise in awareness about advantages of intravenous therapy, and growing demand for storage of blood and other blood products is likely to open up new growth opportunities for the market in the upcoming years.
The global injectable bags market is mainly classified on the basis of material, capacity, chamber, application, distribution channel, and geography. The material type segment includes polypropylene (PP), polyvinylchloride (PVC), ethylene vinyl acetate, PC, and other material types. The capacity type segment covers 0-250 ml, 250-500 ml, 500-1000 ml, and above 1000 ml. By chamber, the classification includes single chamber, and multi chamber. Application segment is further bifurcated into blood storage, blood transfusion, medications, and electrolyte imbalance. Furthermore, the distribution channel segment is categorized into hospital pharmacies, retail pharmacies, and online pharmacies.
Based on geography, the global injectable bags market is segmented into North America, Europe, Asia-Pacific, and Rest of the World (RoW). North America is further bifurcated in U.S., Canada, and Mexico whereas Europe consists of UK, Germany, France, Italy, and Rest of Europe. Asia-Pacific is segmented into India, China, Japan, South Korea, and Rest of Asia-Pacific while RoW is bifurcated into South America, Middle East, and Africa.
Key players operating in the market include B.Braun Melsungen AG, Otsuka Pharmaceutical India Private Limited, Kraton Corporation, Hospira Inc. (Pfizer, Inc.), Haemotronic S.p.A, Baxter International Inc., Macopharma SA, Medline Industries, Inc., ICU Medical, Inc., and West Pharmaceutical Services Inc., among others.
The key takeaways from the report
- The report will provide detailed analysis of the Global Injectable Bags Market with respect to major segments such as material, capacity, chamber, application, distribution channel, and geography
- The report will include the qualitative and quantitative analysis with market estimation over 2016 – 2025 and compound annual growth rate (CAGR) between 2017 and 2025
- Comprehensive analysis of market dynamics including factors and opportunities will be provided in the report
- An exhaustive regional analysis of the Global Injectable Bags Market has been included in the report
- Profile of the key players in the Global Injectable Bags Market will be provided, which include key financials, product & services, new developments and business strategies
Scope of the Global Injectable Bags Market
- Polypropylene (PP)
- Polyvinylchloride (PVC)
- Ethylene Vinyl Acetate,
- Others Material Types
- 0-250 ml,
- 250-500 ml,
- 500-1000 ml
- Above 1000 ml
Chamber Type Segments
- Single chamber
- Multi chamber
- Blood Storage
- Blood transfusion
- Electrolyte Imbalance
- Hospital Pharmacies,
- Retail Pharmacies
- Online Pharmacies
- North America
- Rest of Europe
- South Korea
- Rest of Asia-Pacific
- South America
- Middle East